Gary A Lyons
Director at Neurocrine Biosciences Inc (NBIX)
Gary A Lyons has filed 44 insider reports with the SEC since January 2021, as director at Neurocrine Biosciences Inc (NBIX), director at Travere Therapeutics, Inc. (TVTX) and director at Rigel Pharmaceuticals Inc (RIGL) and at 2 more companies. In the last 12 months Gary A Lyons sold $5.72M of stock on the open market. In the latest filing, on November 19, 2026, Gary A Lyons sold 15,000 shares of Neurocrine Biosciences Inc (NBIX) for $2.47M at an average of $164.87.
- Filings
- 44
- Companies
- 5
- Bought on market
- None
- Sold on market
- $18.3M
Companies where Gary A Lyons is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 122,141 | $16.8M | $156.59 | Nov 19, 2026 | |||
| Director | 61,500 | $1.55M | $48.30 | Aug 19, 2026 | |||
| Director | 75,000 | $41.19 | Jul 12, 2023 | ||||
| Director | $1.90 | May 2, 2023 | |||||
| Director | May 17, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 17, 2026-$2.47MNBIXDirector Gary A Lyons exercised 15,000 shares at a strike of $53.64 and sold $2,473,030 worth of shares (15,000 units at $164.87) as part of a pre-agreed trading plan, increasing direct ownership by 3% to 126,241 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 18, 2026-$633KTVTXDirector Lyons Gary A exercised 10,000 shares at a strike of $17.44 and sold $632,846 worth of shares (10,000 units at $63.28) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 18, 2026~$318KTVTXGary A Lyons plans to sell 5,000 shares (~$318K)Form 144Planned sale10b5-1 plan
- Aug 17, 2026~$311KTVTXGary A Lyons plans to sell 5,000 shares (~$311K)Form 144Planned sale10b5-1 plan
- May 27, 2026NBIXSEC Form 4 filed by Director Lyons Gary AForm 4Grant or award
- May 21, 2026NBIXDirector Lyons Gary A converted options into 1,659 shares, increasing direct ownership by 1% to 122,141 unitsForm 4Exercise or conversion of a derivative
- May 19, 2026TVTXDirector Lyons Gary A was granted 4,000 shares, increasing direct ownership by 7% to 61,500 unitsForm 4Grant or award
- Apr 14, 2026-$329KTVTXSEC Form 4 filed by Lyons Gary AForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 14, 2026~$246KTVTXGary A Lyons plans to sell 8,000 shares (~$246K)Form 144Planned sale10b5-1 plan
- Dec 3, 2025-$2.29MNBIXDirector Lyons Gary A sold $2,289,082 worth of shares (15,000 units at $152.61) and exercised 15,000 shares at a strike of $47.89, increasing direct ownership by 12% to 135,482 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 22, 2025NBIXDirector Lyons Gary A converted options into 1,435 shares, increasing direct ownership by 1% to 120,482 unitsForm 4Grant or awardExercise or conversion of a derivative
- May 15, 2025TVTXDirector Lyons Gary A was granted 6,500 shares, increasing direct ownership by 13% to 57,500 unitsForm 4Grant or award
- Oct 4, 2024-$589KTVTXDirector Lyons Gary A exercised 40,000 shares at a strike of $10.48 and sold $589,101 worth of shares (40,000 units at $14.73)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 4, 2024~$546KTVTXGary A Lyons plans to sell 40,000 shares (~$546K)Form 144Planned sale10b5-1 plan
- Aug 13, 2024-$1.74MNBIXDirector Lyons Gary A exercised 11,570 shares at a strike of $42.76 and sold $1,740,450 worth of shares (11,570 units at $150.43)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 16, 2024-$140KNBIXDirector Lyons Gary A exercised 930 shares at a strike of $42.76 and sold $139,530 worth of shares (930 units at $150.03)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 22, 2024NBIXSEC Form 4 filed by Lyons Gary AForm 4Grant or award
- May 17, 2024NBIXLyons Gary A converted options into 2,100 sharesForm 4Exercise or conversion of a derivative
- May 14, 2024-$1.7MNBIXLyons Gary A sold $1,695,370 worth of shares (12,500 units at $135.63) and exercised 12,500 shares at a strike of $42.76Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 8, 2024TVTXLyons Gary A was granted 6,500 shares, increasing direct ownership by 15% to 51,000 unitsForm 4Grant or award
- Dec 22, 2023-$1.3MNBIXLyons Gary A sold $1,300,443 worth of shares (10,000 units at $130.04)Form 4Open-market sale10b5-1 plan
- Dec 1, 2023-$584KNBIXLyons Gary A exercised 5,000 shares at a strike of $12.98 and sold $583,837 worth of shares (5,000 units at $116.77), increasing direct ownership by 2% to 208,697 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 12, 2023-$575KNBIXSEC Form 4: Lyons Gary A exercised 5,000 shares at a strike of $12.98 and sold $575,120 worth of shares (5,000 units at $115.02), increasing direct ownership by 2% to 208,697 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 1, 2023-$550KNBIXSEC Form 4: Lyons Gary A exercised 5,000 shares at a strike of $12.98 and sold $550,316 worth of shares (5,000 units at $110.06), increasing direct ownership by 2% to 208,697 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 26, 2023RIGLSEC Form 4 filed by Lyons Gary AForm 4Grant or award
- May 17, 2023NBIXSEC Form 4 filed by Lyons Gary AForm 4Grant or award
- May 17, 2023TVTXSEC Form 4 filed by Lyons Gary AForm 4Grant or award
- May 1, 2023ELDNSEC Form 4 filed by Lyons Gary AForm 4Grant or award
- Feb 1, 2023ELDNSEC Form 4 filed by Lyons Gary AForm 4Grant or award
- Oct 31, 2022-$1.72MNBIXSEC Form 4: Lyons Gary A exercised 15,000 shares at a strike of $12.71 and sold $1,721,403 worth of shares (15,000 units at $114.76) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 218,697 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 4, 2022-$553KNBIXSEC Form 4: Lyons Gary A sold $552,711 worth of shares (5,000 units at $110.54) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- May 20, 2022RIGLSEC Form 4: Lyons Gary A was granted 25,000 shares, increasing direct ownership by 100% to 50,000 unitsForm 4Grant or award
- May 18, 2022NBIXSEC Form 4 filed by Lyons Gary AForm 4Grant or award
- May 17, 2022BBISEC Form 4 filed by Lyons Gary AForm 4Grant or award
- May 11, 2022TVTXSEC Form 4: Lyons Gary A was granted 3,000 shares, increasing direct ownership by 8% to 40,000 unitsForm 4Grant or award
- Apr 25, 2022-$1.39MNBIXSEC Form 4: Lyons Gary A exercised 15,000 shares at a strike of $6.66 and sold $1,391,392 worth of shares (15,000 units at $92.76) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 223,697 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 1, 2022ELDNSEC Form 4 filed by Lyons Gary AForm 4Grant or award
- Oct 7, 2021-$525KNBIXSEC Form 4: Lyons Gary A sold $525,294 worth of shares (5,000 units at $105.06) as part of a pre-agreed trading planForm 4Open-market sale10b5-1 plan
- Jun 10, 2021-$1MNBIXSEC Form 4: LYONS GARY A sold $1,002,743 worth of Common Stock (10,000 units at $100.27)Form 4Open-market sale10b5-1 plan
- Jun 14, 2021BBISEC Form 4 filed by LYONS GARY AForm 4Grant or award
- May 19, 2021RIGLSEC Form 4: LYONS GARY A was granted 25,000 units of Common StockForm 4Grant or award
- May 19, 2021NBIXSEC Form 4 filed by LYONS GARY AForm 4Grant or award
- May 14, 2021TVTXSEC Form 4: LYONS GARY A was granted 3,000 units of Common Stock, increasing direct ownership by 9% to 37,000 unitsForm 4Grant or award
- Jan 26, 2021-$240KNBIXSEC Form 4: A Gary Lyons sold $240,047 worth of Common Stock (2,000 units at $120.02)Form 4Open-market sale10b5-1 plan
Compare Gary A Lyons with
- Gary A Lyons vs Eiry Roberts1 shared
- Gary A Lyons vs George J Morrow1 shared
- Gary A Lyons vs Kyle Gano1 shared
- Gary A Lyons vs William E. Rote1 shared
- Gary A Lyons vs Peter Heerma1 shared
- Gary A Lyons vs Jula Inrig1 shared
Other insiders at the same companies
- Eiry RobertsNBIX
- George J MorrowNBIX
- Kyle GanoNBIX
- William E. RoteTVTX
- Peter HeermaTVTX
- Jula InrigTVTX
- Elizabeth E ReedTVTX
- Eric M DubeTVTX
- Christopher R. ClineTVTX
- Sandra CalvinTVTX
- Jude OnyiaNBIX
- Darin LippoldtNBIX
- Sanjay Chandru KeswaniNBIX
- Kevin Charles GormanNBIX
- Ingrid DelaetNBIX
- Julie CookeNBIX
Questions about Gary A Lyons
- What is Gary A Lyons's role at Neurocrine Biosciences Inc?
- Gary A Lyons reports to the SEC as director at Neurocrine Biosciences Inc (NBIX), according to the latest filing on November 19, 2026. Gary A Lyons has also filed as director at Travere Therapeutics, Inc. (TVTX), director at Rigel Pharmaceuticals Inc (RIGL), director at Eledon Pharmaceuticals, Inc. (ELDN) and director at Brickell Biotech, Inc. (BBI).
- How many shares does Gary A Lyons own?
- After the latest filing that states it, Gary A Lyons directly owned 122,141 shares of Neurocrine Biosciences Inc (NBIX), 61,500 shares of Travere Therapeutics, Inc. (TVTX) and 75,000 shares of Rigel Pharmaceuticals Inc (RIGL). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Gary A Lyons bought or sold stock recently?
- The most recent open-market sale was on November 17, 2026: sold 15,000 shares of Neurocrine Biosciences Inc (NBIX) for $2.47M at an average of $164.87.
- How do I get alerts when Gary A Lyons files?
- Follow Gary A Lyons on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Gary A Lyons filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Gary A Lyons (SEC CIK 0001123343). Totals count each trade once, skipping amendments whose original is on file, from Jan 28, 2021 on. View on SEC EDGAR · Get this as JSON